Exagen Inc (XGN)

Apr 24, 2026

Exagen Inc. (NASDAQ:XGN) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Apr 24, 2026

Apr 23, 2026

Exagen Announces Board Resignation and Committee Restructuring - TipRanks

Apr 23, 2026

Apr 23, 2026

Ana Hooker resigns from Exagen Board; board size falls to seven - TradingView

Apr 23, 2026

Apr 23, 2026

Board reshuffle at Exagen (NASDAQ: XGN) as Ana Hooker steps down - Stock Titan

Apr 23, 2026

Apr 21, 2026

Exagen (NASDAQ: XGN) director reports 7,500 restricted stock units - Stock Titan

Apr 21, 2026

Apr 20, 2026

XGN Maintained by Canaccord Genuity -- Price Target Lowered to $8.00 - GuruFocus

Apr 20, 2026

Apr 17, 2026

Does Exagen (XGN)’s 200%+ upside potential make it one of the best penny stocks set to explode? - MSN

Apr 17, 2026

Apr 15, 2026

Exagen Inc. (NASDAQ:XGN) Short Interest Update - MarketBeat

Apr 15, 2026

Apr 14, 2026

Exagen Inc stock (US30063K1051): Is its autoimmune testing edge strong enough to unlock new upside? - AD HOC NEWS

Apr 14, 2026

Apr 14, 2026

Exagen announces resale of up to 1.15M shares - MSN

Apr 14, 2026

Apr 13, 2026

Aug Intraday: Will Exagen Inc benefit from current market trendsQuarterly Market Summary & Daily Stock Trend Reports - baoquankhu1.vn

Apr 13, 2026

Apr 13, 2026

Exagen (XGN) price target decreased by 21.78% to 10.03 - MSN

Apr 13, 2026

Apr 12, 2026

Does Exagen (XGN)’s 200%+ Upside Potential Make It One of the Best Penny Stocks Set to Explode? - Insider Monkey

Apr 12, 2026

Apr 11, 2026

5 Stocks Under $5 That Will Explode - Insider Monkey

Apr 11, 2026

Apr 11, 2026

BTIG Maintains Exagen (XGN) Buy Recommendation - MSN

Apr 11, 2026

Apr 09, 2026

Will Exagen Inc benefit from geopolitical trends2026 Chart Watch & Technical Pattern Recognition Alerts - baoquankhu1.vn

Apr 09, 2026

Apr 08, 2026

How does news flow impact Exagen (XGN) Stock | Price at $2.97, Down 1.00%Expert Breakout Alerts - Xã Thanh Hà

Apr 08, 2026

Apr 06, 2026

Is Exagen (XGN) Stock Consolidating | Price at $3.20, Up 4.58%Community Trade Ideas - Cổng thông tin điện tử tỉnh Lào Cai

Apr 06, 2026

Apr 05, 2026

Exagen (XGN) Price Target Increased by 12.20% to 13.41 - MSN

Apr 05, 2026

Apr 04, 2026

XGN PE Ratio & Valuation, Is XGN Overvalued - Intellectia AI

Apr 04, 2026

Apr 03, 2026

XGN Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 03, 2026

Mar 30, 2026

Exagen Inc. (NASDAQ:XGN) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Mar 30, 2026

Mar 29, 2026

CEO Change: Is Exagen Inc benefiting from innovation trendsMarket Growth Review & Reliable Entry Point Trade Alerts - baoquankhu1.vn

Mar 29, 2026

Mar 27, 2026

How Analyst Resets Are Reshaping The Exagen (XGN) Investment Story - finance.yahoo.com

Mar 27, 2026

Mar 25, 2026

Exagen Inc stock gains spotlight ahead of Maryland MedTech Summit 2026 amid diagnostic innovation pu - AD HOC NEWS

Mar 25, 2026

Mar 22, 2026

Stop Loss: Is Exagen Incs growth already priced inGap Up & High Accuracy Trade Alerts - baoquankhu1.vn

Mar 22, 2026

Mar 16, 2026

Exagen (XGN) director lists 7,500 restricted stock units in Form 3 - Stock Titan

Mar 16, 2026

Mar 16, 2026

Exagen (XGN) CFO receives option, RSU grants and ESPP share purchase - Stock Titan

Mar 16, 2026

Mar 16, 2026

Exagen (XGN) CEO John Aballi awarded new RSUs and options - Stock Titan

Mar 16, 2026

Mar 16, 2026

Exagen prices public offering of common stock - MSN

Mar 16, 2026

Mar 15, 2026

Exagen Inc Stock (ISIN: US30063K1051) Faces Headwinds After 2025 Revenue Beat - AD HOC NEWS

Mar 15, 2026

Mar 14, 2026

Exagen Inc Stock (ISIN: US30063K1051) Faces Headwinds After 2025 Revenue Beat and Cautious 2026 Outl - AD HOC NEWS

Mar 14, 2026

Mar 14, 2026

Exagen (NASDAQ:XGN) Downgraded by Wall Street Zen to Sell - MarketBeat

Mar 14, 2026

Mar 13, 2026

Exagen Q4 Earnings Call Highlights - Defense World

Mar 13, 2026

Mar 12, 2026

Exagen Inc. 2025 Annual Report: Innovative AVISE® Autoimmune Disease Testing, Business Strategy, Pipeline, and Intellectual Property Overview - Minichart

Mar 12, 2026

Mar 11, 2026

Exagen stock price target lowered to $10 by Canaccord on margin outlook - Investing.com UK

Mar 11, 2026

Mar 11, 2026

KeyBanc cuts Exagen stock price target on pricing headwinds - Investing.com Nigeria

Mar 11, 2026

Mar 11, 2026

Exagen (XGN): Canaccord Genuity Lowers Price Target to $10.00 | - GuruFocus

Mar 11, 2026

Mar 11, 2026

Canaccord Genuity Group Issues Pessimistic Forecast for Exagen (NASDAQ:XGN) Stock Price - MarketBeat

Mar 11, 2026

Mar 11, 2026

Analyst John Wilkin Lowers Price Target for Exagen (XGN) | XGN S - GuruFocus

Mar 11, 2026

Mar 11, 2026

KeyBanc cuts Exagen stock price target on pricing headwinds By Investing.com - Investing.com India

Mar 11, 2026

Mar 11, 2026

Exagen (NASDAQ:XGN) Price Target Cut to $10.00 by Analysts at Craig Hallum - MarketBeat

Mar 11, 2026

Mar 11, 2026

XGN: Keybanc Lowers Price Target to $10, Maintains Overweight Ra - GuruFocus

Mar 11, 2026

Mar 11, 2026

KeyCorp Issues Pessimistic Forecast for Exagen (NASDAQ:XGN) Stock Price - MarketBeat

Mar 11, 2026

Mar 11, 2026

Exagen Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:XGN) 2026-03-11 - Seeking Alpha

Mar 11, 2026

Mar 11, 2026

Exagen stock price target lowered to $10 by Canaccord on margin outlook By Investing.com - Investing.com Canada

Mar 11, 2026